Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.380
-0.070 (-4.83%)
At close: Mar 20, 2026, 4:00 PM EDT
1.390
+0.010 (0.72%)
After-hours: Mar 20, 2026, 7:34 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $389.98 million as of March 20, 2026. Its market cap has increased by 216.53% in one year.
Market Cap
389.98M
Enterprise Value
165.79M
1-Year Change
216.53%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $389.98M, a decrease of -82.79%. That is a compound annual growth rate of -31.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 389.98M | -43.03% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 415.95M |
| Lexeo Therapeutics | 412.38M |
| Ginkgo Bioworks Holdings | 395.38M |
| X4 Pharmaceuticals | 389.14M |
| YD Bio | 383.95M |
| Nautilus Biotechnology | 382.70M |
| PureTech Health | 381.76M |
| Benitec Biopharma | 377.21M |